Coriolis Pharma, a global contract research and development organization, celebrated the grand opening of its new North America headquarters and laboratory, marking the start of operations at the ...

More than 100 Research Triangle Park officials and other supporters gathered on Thursday for a celebration at HUB RTP to mark the culmination of a multi-year planning process to chart a new long-range ...

Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has raised $12 million from investors, including two North Carolina venture capital ...

Two life sciences organizations with operations in North Carolina are planning major expansions that will bring over 1,500 jobs and $1.8 billion in investment to the Greater Charlotte region.

North Carolina is a mecca for biopharmaceutical contract service providers. One of the biggest in the state and the sector, Syneos Health, is getting even bigger through the acquisition of Synteract.

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human therapeutics, will collaborate with Novo Nordisk A/S to co-develop oral therapies ...

I had the opportunity to participate in a panel discussion reflecting on my experiences working with both EBRC and the ...

Biomason of Research Triangle Park has raised $65 million in Series C financing to accelerate development of its technology for growing biocement with bacteria. “This investment marks an important ...

Our state is home to a broad range of natural resources and scientific knowledge that, when combined, can transform communities from Manteo to Murphy. To bring that vision to reality, we opened our ...